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Introduction
Integrins are heterodimeric cell surface receptors, consisting of 
an α and a β subunit, which play an important role in cell mi-
gration and tissue integrity by mediating cell attachment to the 
surrounding ECM and to other cells (Brakebusch and Fässler, 
2005). Integrins can adopt high- and low-affi  nity conforma-
tions, and ligand binding to integrins is preceded by intracellu-
lar changes, resulting in increased integrin affi  nity (inside-out 
signaling; Ginsberg et al., 2005). Tight regulation of integrin 
affi  nity is crucial for the physiological function of integrins. 
 During  infl  ammation, for example, leukocytes can only extrava-
sate into the affected tissue after a chemokine-induced increase 
in integrin affi  nity (Sackstein, 2005). Similarly, blood clotting is 
restricted to wounds by effi  cient control of the affi  nity of plate-
let integrin (Bennett, 2005).
Although the molecular mechanisms controlling   integrin-
mediated adhesion by inside-out signaling are not well under-
stood, much is known about the structural changes that occur 
during integrin activation (Arnaout et al., 2005). Crystal structure 
analysis suggests a bent, hooklike conformation of the extracel-
lular domain for the inactive state and an extended conforma-
tion in the active, high-affi  nity state (Takagi and Springer, 2002). 
Recent three-dimensional EM structural analysis, however,
demonstrates that the bent conformation of αvβ3 is also able 
to bind effi  ciently to ligands, at least in the presence of Mn
2+, 
indicating that Mn
2+-induced activation takes place through 
small local conformational changes and not by straightening 
the extracellular domain (Adair et al., 2005). Although all these 
studies were done with β3 integrins, the conclusions conceiv-
ably can be extended to β1 integrin because of the high extent 
of structural similarity.
Many lines of experimental evidence indicate that bind-
ing of talin to the cytoplasmic domain of β1 integrin is a fi  nal 
common step in integrin activation (Liddington and Ginsberg, 
2002; Tadokoro et al., 2003). Talin is a rodlike molecule with 
a globular head domain, which links integrins to the actin 
  cytoskeleton. It binds to the membrane-proximal NPXY motif 
of β1, β2, and β3 integrin via a phosphotyrosine binding–like 
region in the FERM domain of the talin head. This binding 
is suggested to disrupt a salt bridge between the α and β sub-
units, which is believed to keep the integrin in an inactive state 
(Vinogradova et al., 2002). In addition, specifi  c van der Waals 
interactions between the transmembrane regions of the α and β 
subunits are supposedly altered after talin binding, leading to 
conformational changes that are propagated across the plasma 
membrane, resulting in integrin activation (Luo et al., 2004). 
Talin binding to integrin is promoted by proteolytic cleavage 
of talin and binding of phosphoinositol phosphates and may 
be regulated by phosphorylation of talin (Critchley, 2005). 
It was proposed that phosphorylation of the NPXY motif in the 
integrin β subunit interferes with integrin activation by talin 
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in two different ways. First, tyrosine phosphorylation of the 
NPXY motif might reduce the affi  nity for talin to such an ex-
tent that talin can no longer bind the β subunit. Second, NPXY 
phosphorylation might increase the affi  nity for other phospho-
tyrosine binding domain–containing proteins, to competitively 
inhibit the interaction with talin (Calderwood, 2004). Indeed, 
tyrosine-phosphorylated β3 integrin preferably interacts with 
Shc and not with talin (Cowan et al., 2000).
Mutational studies support a negative regulation function 
of tyrosine phosphorylation on integrin activation.  Fibroblastoid 
cells expressing a β1 integrin in which the tyrosines in both 
NPXY motifs were substituted with nonphosphorylatable phen-
ylalanines (YY783/795FF) were able to more effectively bind 
and assemble fi  bronectin (FN), similar to β1 mutants in which 
formation of the salt bridge to the α subunit is prohibited 
(D759A; Sakai et al., 1998a). In addition, YY783/795FF mutants 
showed partially altered outside-in signaling characterized by 
defective FAK activation but normal p130Cas phosphorylation 
(Wennerberg et al., 2000). Transformation with v-src results 
in tyrosine phosphorylation of β1 integrin, correlating with 
 decreased  β1 integrin–mediated adhesion (Sakai et al., 2001). 
V-src did not induce decreased adhesion in the nonphosphory-
latable YY783/795FF β1 mutant, suggesting that tyrosine 
  phosphorylation of integrins inhibits integrin activation and 
contributes to cell transformation by v-src.
In this study, we investigated the mechanism of integrin 
activation under physiological conditions and generated mice in 
which we replaced endogenous β1 integrin by mutant forms of β1, 
lacking either the aspartic acid essential for the salt bridge with 
the α subunit (D759A) or the tyrosine residues of the two cyto-
plasmic NPXY motifs (YY783/795FF), thus preventing inactiva-
tion by tyrosine phosphorylation. Surprisingly, both mutations did 
not cause any obvious phenotype, indicating that neither the salt 
bridge nor the phosphorylation of the intracellular tyrosines of β1 
integrin is important for the regulation of β1 integrin   activation. 
Substitution of the tyrosines with alanines (YY783/795AA), 
however, completely abolished β1 integrin function, confi  rming 
the crucial role of the NPXY motifs for integrin activation.
Results
Generation of mice carrying point 
mutations in the cytoplasmic domain–
encoding region of the 𝗃1 integrin gene
To study the role of amino acid residues and protein motifs im-
portant for integrin activation during mouse development as well 
as in adult tissues, we established several mouse strains with 
point mutations in the cytoplasmic domain of the β1A integrin 
subunit (Fig. 1). First, we tested the relevance of the membrane-
proximal salt bridge between α and β1 subunits by exchanging 
the aspartic acid residue 759 to alanine (D759A [D/A]), which 
destroys the salt bridge. Second, we addressed the potential role 
of tyrosine phosphorylation of the two conserved NPXY motifs 
within the β1 cytoplasmic domain, the proximal of which was 
shown to recruit talin. To this end, we established mice in which 
one or both tyrosines were exchanged to the nonphosphorylat-
able phenylalanine (Y783F; Y795F; YY783/795FF [YY/FF]). 
A nonconservative change of the NPXY motifs was achieved by 
replacing the tyrosines by alanine (YY783/795AA [YY/AA]).
All mutations were introduced by homologous recombi-
nation into embryonic stem (ES) cells (Fig. 2, A and B) and 
confi  rmed by sequence analysis (not depicted). Positive ES cell 
clones of each mutation were injected into blastocysts to estab-
lish the mutant knock-in (KI) mouse strains (KI
neo+; Fig. 2, A 
and B). The loxP-fl  anked neomycin gene was then removed by 
intercrossing the mutant mouse strains with a deleter-Cre strain, 
resulting in mice carrying an intronic loxP site and defi  ned point 
mutations in the following exon of the β1 integrin gene (KI
lox; 
Fig. 2, A and B).
To exclude adverse effects of the intronic loxP sites, we 
established mice carrying only a loxP site in front of exon 15 or 
16 but no mutation in the exons (E15
lox and E16
lox).  Homozygous 
E15
lox/lox and E16
lox/lox animals were born at the expected Men-
delian ratio, were fertile, had a normal life span, and did not 
display any overt phenotype (Fig. S1, A and B, available at 
http://www.jcb.org/cgi/content/full/jcb.200604060/DC1; and 
not depicted). FACS analysis revealed normal expression and 
activation of β1 integrin (Fig. S4).
Because impaired β1 integrin function severely affects 
interfollicular epidermis and hair follicle cycling (Brakebusch 
et al., 2000), we chose to more closely investigate the skin of 
these mice for defects. E15
lox/lox and E16
lox/lox showed normal skin 
development, and no hyperthickening of the epidermis, blister 
formation, or dermal fi  brosis could be observed.   Similarly, the 
hair follicle frequency, length, and morphology were unaffected 
in E15
lox/lox and E16
lox/lox mice (Fig. S1, C and D).
Finally, RT-PCR analysis of the cytoplasmic domain of 
the β1 integrin mRNA from lox/lox wild-type and lox/lox mu-
tant keratinocytes revealed a normal level of β1 integrin expres-
sion and faithful splicing of the cytoplasmic exons to generate 
the β1A mRNA (Fig. 2 G). RNA samples from striated muscle 
were used to amplify the muscle-specifi  c exon D β1 integrin 
isoform (β1D). Neither the introduction of the loxP site up-
stream of exon 15 or 16 nor the point mutations in exon 15 or 
exon 16 led to isoform switching. Altogether, these fi  ndings in-
dicate that the presence of the single loxP in the intron preced-
ing exon 15 or 16 of the β1 integrin gene did not affect integrin 
expression and function.
D759A mutation does not affect 𝗃1 
integrin function
Homozygous D/A mutant mice lacking the salt bridge con-
necting the β1 and α subunits were born at the Mendelian ratio 
Figure 1.  Amino acid alignment of the cytoplasmic regions of wild-type 
and mutant 𝗃1A integrin subunits. Mutated residues are highlighted in red, 
and regions encoded by exons 15 and 16 are indicated by solid lines.β1 INTEGRIN ACTIVATION IN VIVO • CZUCHRA ET AL. 891
(not depicted), as determined by genotyping of the heterozy-
gous D/A intercrosses (Fig. 2 C). The mutant mice were fertile 
and had a normal life span. Furthermore, D/A mutant mice had 
normal growth rates (Fig. S2, A and B, available at http://www.
jcb.org/cgi/content/full/jcb.200604060/DC1) and did not dis-
play any obvious impairments (Fig. 2 E).
Detailed histological analysis of the mutant skin at 
postnatal day (P) 1, P7, P14, P21, and 3 mo revealed normal 
interfollicular epidermis, normal epidermal–dermal junction, 
and normal hair follicle formation and progression through 
the hair cycle (Fig. 3 A and not depicted). As in control skin, 
immunostaining of the D/A mutant skin showed β1 integrin 
and α6 integrin restricted to basal keratinocytes and lam-
inin 5 (LN5) deposition at the dermal–epidermal junction 
(Fig. 3, B and C; and not depicted). Furthermore, prolife-
ration as   determined by BrdU incorporation was normal in 
the basal keratinocytes expressing the D/A mutant integ-
rin, with 11.1 ± 0.07% BrdU-positive cells in control and 
11.2 ± 2.26% in the D/A mutant mice in 14-d-old mice and 
3.5 ± 0.14 and 3.7 ± 0.42% in 3-mo-old mice, respectively. 
  Similarly, the proliferation of hair bulb cells was unaltered 
(unpublished data).
Figure 2.  Targeting strategy for introducing 
point mutations in the cytoplasmic domain of 
the 𝗃1A integrin. (A and B) Partial map of the 
β1A wild type (wt), the KI allele with a point 
mutation (indicated by asterisk) in exon 15 
(E15; A) or exon 16 (E16; B), respectively, 
before (KI
neo+) and after (KI
lox) Cre-mediated 
deletion of the ﬂ  oxed neo cassette. The DNA 
fragment sizes obtained after BamHI restriction 
digest, as well as the probe used for South-
ern blotting are indicated. Filled boxes indi-
cated exons, and triangles indicate loxP sites. 
D, exon D; neo, neomycin resistance gene; 
pA, polyadenylation signal. (C and D) Repre-
sentative PCR genotyping of KI
lox mice using 
primers ﬂ   anking either the loxP site in intron 
14 (C) or intron 15 (D), respectively. (E and F) 
Control, D/A (E), and YY/FF (F) mutant mice 
of 3 mo of age. (G) Nonquantitative RT-PCR 
performed with primers hybridizing to exons 
14 and 16 of the β1 integrin cDNA from tem-
plate RNA derived from keratinocytes of exon 
15 and 16 control mice and KI littermates. The 
RNA samples from both the control and the 
mutant keratinocytes revealed a single PCR 
product of the expected size of 389 bp. The 
468-kb band represents the transcript size for 
the wild-type β1D integrin mRNA, which is the 
muscle-speciﬁ  c isoform of the β1 integrin gene 
and only detectable in muscle RNA.
Figure 3.  Normal skin development in D/A 
and YY/FF mutant mice. (A and D) HE-stained 
back skin of P7, -14, and -21 mice shows nor-
mal hair cycle progression in D/A (A) and 
YY/FF (D) mutant mice. (B and E) Back skin of 
2-wk-old control and D/A (B) and YY/FF (E) 
mutant animals stained for β1 integrin (red) 
and  α6 integrin (green). Immunostaining for 
β1 and α6 integrin subunits reveals normal in-
tegrin expression in the skin. (C and F) Immuno-
staining of 2-wk-old back skin for LN5 shows 
normal LN5 deposition at the epidermal–
  dermal junction in control and mutant skin. 
Bars, 50 μm.JCB • VOLUME 174 • NUMBER 6 • 2006  892
Tyrosine phosphorylation of the NPXY 
motifs is not required for development
To investigate the role of tyrosine phosphorylation of the β1 
subunit for embryonic and postnatal development, we inter-
crossed heterozygous Y783F and Y795F mice, respectively. 
Surprisingly, both mutant mouse strains were viable and fertile 
(Fig. S1 E). The lack of an obvious phenotype in the single-
  tyrosine mutant mice prompted us to investigate mice in which 
both tyrosine residues were changed to phenylalanine (YY/FF). 
Astonishingly, the homozygous YY/FF mutant mice (Fig. 2 D) 
were also viable and fertile and, moreover, did not show any ob-
vious phenotype. Their weight and size was comparable to the 
age-matched littermate controls at all time points analyzed (Fig. 
S2, C and D). Furthermore, histological analysis of back skin 
at P1, P7, P14, P21, and 6 mo did not reveal any abnormalities 
with respect to the morphology of the interfollicular epidermis 
and the hair follicles (Fig. 3 D and not depicted). Regardless of 
their age, YY/FF mutant mice displayed neither skin blisters nor 
signs of dermal fi  brosis. Immunostaining of skin sections from 
14-d- and 6-mo-old homozygous YY/FF mutant mice revealed 
normal expression of the β1 and α6 integrin subunits (Fig. 3 E 
and not depicted) and normal deposition and assembly of LN5 
at the epidermal–dermal junction (Fig. 3 F and not depicted). 
Finally, the number of proliferating cells in the basal layer of 
the epidermis was not changed in the mutant skin, with 8.4 ± 
0.14% BrdU-positive cells in control and 10 ± 0.21% in YY/YY
mutant mice at 14 d of age and 3.55 ± 0.63 and 2.85 ± 0.78%, 
respectively, at 6 mo of age. Furthermore, the proliferation of 
hair bulb cells was similar in control and YY/FF mutant hair 
follicles (unpublished data).
Primary D/A and YY/FF mutant 
keratinocytes have normal adhesion, 
spreading, and migration in vitro
If loss of the salt bridge and prevention of tyrosine phosphory-
lation increase integrin activation, this should have conse-
quences for β1 integrin–mediated adhesion, spreading, and 
migration. Although defects in these parameters were not obvi-
ous in the context of skin, we isolated primary keratinocytes to 
test these parameters in cellular assays.
Both the D/A and YY/FF mutant cells attached to a mix-
ture of collagen I (Col1) and FN-coated surface, spread, and 
grew in a manner indistinguishable from control cells (unpub-
lished data). In vitro–expanded D/A and YY/FF keratinocytes 
were assayed for their ability to adhere to increasing concentra-
tions of LN5, Col1, and FN. Dose-dependent adhesion of D/A 
mutant keratinocytes (Fig. 4 A) and YY/FF mutant keratino-
cytes (Fig. 4 B) was comparable to their respective control cells 
on all matrix substrates analyzed (Fig. 4, A and B). Similarly, 
the D/A as well as the YY/FF mutant keratinocytes spread to a 
similar extent on a Col1/FN mixture as control cells (Fig. 4 C 
and not depicted).
Figure 4.  D/A and YY/FF mutant keratinocytes adhere and migrate normally in vitro. (A and B) Dose-dependent cell adhesion of D/A (A) and YY/FF (B) 
keratinocytes on LN5, FN, and Col1 is similar compared with control cells. Error bars indicate SD. Shown is the mean value of three independent 
  experiments. (C) Control and YY/FF mutant keratinocytes were plated on Col1/FN-coated plastic and monitored by live cell imaging. Quantiﬁ  cation of the 
cell area of 50 randomly selected cells per time point and genotype is shown. Error bars indicate SD. The extent of spreading of YY/FF mutant keratinocytes 
is not signiﬁ  cantly different from control cells. (D) Keratinocytes were cultured for 2 d on a mixture of Col1 and FN and immunostained for β1 integrin, paxil-
lin and vinculin (red), and F-actin (phalloidin; green). Nuclei were stained with DAPI (blue). Size and number of FAs and actin stress ﬁ  bers is normal in D/A 
mutant keratinocytes. (E) Normal and YY/FF mutant keratinocytes were stained for talin (red), FAK (green), and pY397FAK upon plating on a mixture of 
Col1 and FN. Size and number of FAs and localization of talin, FAK, and pY397FAK is normal in YY/FF mutant keratinocytes. Bars shows ratiometric analy-
sis of talin and FAK signals in talin/FAK double-immunostained YY/FF mutant keratinocytes. Shown is the mean value of 27 cells analyzed per genotype. 
The ratio of talin/FAK signals is identical in the FAs of the YY/FF mutant cells. Bars, 10 μm.β1 INTEGRIN ACTIVATION IN VIVO • CZUCHRA ET AL. 893
To investigate focal contact organization and F-actin dis-
tribution in mutant keratinocytes, cells were cultured for 2 d on 
a Col1/FN mixture and subsequently stained with antibodies 
against β1 integrin, talin, FAK, pY397FAK, vinculin and paxil-
lin, and fl  uorescently labeled phalloidin. No obvious differences 
were observed in the size or number of focal adhesions (FAs) and 
in F-actin organization (Fig. 4, D and E; and Fig. S3, available 
at http://www.jcb.org/cgi/content/full/jcb.200604060/DC1). 
Similarly, the β1 integrin carrying either the D/A or YY/FF 
  mutation localized normally to FAs (Fig. 4 D and Fig. S3). 
  Furthermore, total FAK, pY397FAK, and talin were found in 
FAs of D/A and YY/FF mutant keratinocytes (Fig. 4 E and 
not depicted). To quantitatively assess the extent of talin recruit-
ment into FA of the YY/FF mutant keratinocytes, we simultane-
ously stained mutant keratinocytes with anti-talin and anti-FAK 
antibodies and subsequently determined the ratio of the mean 
fl  uorescence intensities. The talin/FAK ratios were almost iden-
tical in FAs of control and YY/FF mutant cells (Fig. 4 E), sug-
gesting that the YY/FF mutation does not result in increased 
talin recruitment to integrin adhesion sites.
To test migration of mutant keratinocytes in vitro, we per-
formed transwell migration and scratch assays. In transwell as-
says, control or D/A or YY/FF mutant keratinocytes were plated 
in transwell motility chambers and allowed to migrate toward 
medium lacking or containing EGF. In neither the absence nor 
the presence of EGF was the extent of migration signifi  cantly 
different between control and D/A or control and YY/FF mutant 
keratinocytes (Fig. 5, A and B). In scratch assays, we wounded 
a keratinocyte monolayer and monitored wound closure over a 
period of 6 h. The results demonstrate that the YY/FF mutant 
keratinocytes closed the wound with a speed that was not sig-
nifi  cantly different from control cells (Fig. 5, C and D).
Hyperactivation of β1 integrin could lead to increased 
  activation of downstream signaling molecules such as FAK or 
extracellular signal–regulated kinase (Erk). To assess the activa-
tion status of these integrin effectors, we analyzed wounding-
induced phosphorylation of FAK and Erk in YY/FF keratinocytes. 
No signifi  cant difference was found between control and mu-
tant cells either before or after wounding, suggesting that NPXY 
tyrosine phosphorylation is not crucial for inducing the activity 
of these effector molecules (Fig. 5 E).
No detectable alteration in the activation 
of 𝗃1 integrin in D/A and YY/FF 
mutant mice
Previous studies have suggested that both D/A and YY/FF 
mutations will result in constitutive activation of β1 integrin 
(Sakai et al., 1998a, 1998b). Because the results of our cellular 
assays were inconsistent with constitutively active β1 integrin, 
we examined integrin activation more closely on different pri-
mary cells by measuring the binding of the 9EG7 antibody, 
which recognizes an epitope that is exposed only on activated 
β1 integrins.
Freshly isolated keratinocytes from adult D/A mutant 
mice expressed β1, α2, α6, and β4 integrins at similar levels 
as control keratinocytes (Fig. 6 A). Recognition of the 9EG7 
epitope of the β1 integrin identifi  ed a similarly small fraction 
of   activated β1 integrins on D/A homozygous mutant and 
 control keratinocytes (Fig. 6 A). Primary keratinocytes of YY/FF 
mutant mice had a slightly reduced expression of β1 integrin 
with a similar reduction of the 9EG7 epitope. Expression 
 levels  of  α2 integrin were also slightly decreased, whereas α6 
and β4 integrin were unchanged compared with control cells 
(Fig. 6 B).
The 9EG7 epitope is not easily detected on epidermal ke-
ratinocytes (Bazzoni and Hemler, 1998). In addition, the trypsin 
treatment during the preparation of the keratinocytes may abrogate 
the 9EG7 epitope. Therefore, we also analyzed the β1 integrin ac-
tivation by FACS on granulocytes, macrophages, B-lymphocytes, 
and erythroblasts freshly isolated from the bone marrow of control 
and mutant mice (Fig. S4). Expression of β1 integrin was com-
parable between control and mutant cells, with the exception of 
the granulocytes and macrophages in YY/FF mice, which showed 
a reduction of surface β1 integrin by  50 and 30%, respectively 
(Fig. S4). We could not detect increased basal 9EG7 exposure on 
D/A and YY/FF mutant cells (Fig. S4). Interestingly, treatment 
of cells with 5 mM Mn
2+ markedly increased the 9EG7 epitope 
Figure 5.  Normal migration of the D/A and YY/FF keratinocytes in vitro. 
(A and B) Migration of control, D/A mutant (A), and YY/FF (B) keratinocytes 
through transwell chambers. The bottom chamber contained medium with 
or without EGF, and cells from ﬁ  ve randomly chosen ﬁ  elds that migrated to 
the bottom of the membranes were counted. Bars represent the number of 
migrated cells from three independent experiments. Error bars indicate SD. 
D/A and YY/FF mutant keratinocytes showed migration behavior similar 
to control cells. (C) Control and YY/FF keratinocytes were grown to conﬂ  u-
ence, and the cell monolayer was wounded using a blunted tip of a glass 
capillary. Pictures from the same area of the scratch were taken at the 
indicated time points. Data shown are from one experiment, which was 
repeated twice. Bar, 50 μm. (D) Migration was calculated by measuring 
the remaining width of the scratch. For each experiment, at least 10 areas 
were measured per time point. Error bars indicate SD. (E) Basal activity 
and wound-induced activation of pErk and pFAK does not signiﬁ  cantly dif-
fer between starved (keratinocyte growth medium without FCS) control and 
YY/FF mutant keratinocytes. Tubulin served as a loading control.JCB • VOLUME 174 • NUMBER 6 • 2006  894
exposure to a similar extent on control (E15
lox/lox and E16
lox/lox) 
and D/A or YY/FF mutant cells (Fig. S4).
The assessment of ligand binding is an alternative method 
for evaluating integrin activation. To this end, we expressed 
and fl  uorescently labeled the central cell binding domain of FN 
(FNIII7-10), which is bound by the α5β1 integrin expressed 
on cultured primary keratinocytes. In the presence of 5 mM 
Mn
2+ control, D/A (Fig. 6 C) and YY/FF (Fig. 6 D) mutant ke-
ratinocytes bound the Alexa 647–labeled FNIII7-10 in a dose-
  dependent manner and to a comparable extent (Fig. 6, C and D). 
As expected, the exposure to 2 mM EDTA or Tris-buffered sa-
line alone revealed only very weak or no ligand binding on all 
cell types analyzed (Fig. 6, C and D).
𝗃1 integrin carrying the YY/AA mutation 
is not functional in keratinocytes in vivo
Although heterozygous YY/AA mice were normal, homozy-
gous YY/AA mutant mice died during embryonic development 
(unpublished data). To generate mice that express the YY/AA 
mutation only in keratinocytes, we intercrossed heterozygous 
YY/AA mutant animals with fl  oxed β1 integrin mice expressing 
the Cre recombinase under the keratin 5 (K5) promoter 
  (Brakebusch et al., 2000) to obtain β1(YY/AA/fl  )  K5-Cre 
(YY/AA) mice. Upon Cre-mediated deletion of the fl  oxed β1 
allele, only the YY/AA mutant allele is expressed in keratinocytes. 
The YY/AA mice were born without obvious abnormalities, but 
by 2 wk, skin pigmentation and hair coat development was 
markedly impaired (Fig. 7 A). At 5 wk of age, almost the entire 
hair coat was lost and wounds appeared in mechanically stressed 
regions (unpublished data). This phenotype closely resembled 
the abnormalities observed in mice with a keratinocyte-specifi  c 
deletion of the β1 integrin gene (Brakebusch et al., 2000).
Histological analysis of skin sections further corroborated 
the similarities between the YY/AA and the β1 integrin–null 
mutation. The skin of 14-d-old YY/AA mutant mice displayed 
hyperthickened epidermis with aberrantly shaped cells, blister 
formation at the epidermal–dermal junction, and severe hair fol-
licle abnormalities (Fig. 7, B and C).
To confi  rm that only the YY/AA-mutated β1 integrin was 
expressed in skin, we performed LacZ staining, the expression 
of which indicates the deletion of the fl  oxed β1 integrin allele 
(Brakebusch et al., 2000). The LacZ staining was clearly detect-
able in the interfollicular epidermis and the outer root sheath 
of hair follicles derived from YY/AA mutant mice (Fig. 7 D). 
  Immunostaining revealed that basal and suprabasal keratino-
cytes of mutant mice express β1 integrin (Fig. 7 E, arrowheads 
indicate suprabasal expression), although the staining was par-
tially discontinuous (not depicted). Similarly, the staining of the 
α6 integrin was discontinuous. Interestingly, β1 integrin is ex-
pressed in regions of skin blistering, suggesting that the mutant 
Figure 6.  Integrin expression and activation on D/A and YY/FF mutant keratinocytes. (A and B) Cell surface expression of integrins in freshly isolated 
  keratinocytes from adult mice assessed by FACS analysis. Keratinocytes are stained with antibodies against β1, α2, β4, and α6 integrins and the 9EG7 
epitope of β1 integrins. (A) Blue and black histograms denote control and D/A mutant keratinocytes, respectively. The background ﬂ  uorescence is shown 
as a dotted line. Mutant D/A keratinocytes show normal integrin expression and normal β1 activation. Shown are representative histograms from three 
  independent experiments. (B) Blue and black histograms denote control and YY/FF mutant keratinocytes, respectively. The expression level of β1 and α2 
  integrins is reduced on YY/FF keratinocytes when compared with the keratinocytes from control mice. The levels of β4 and α6 integrins are normal. Staining 
with the 9EG7 antibody reveals reduced signals on the YY/FF keratinocytes corresponding to the reduced expression of the β1 integrin subunit. Shown are 
representative histograms from three independent experiments. (C and D) Ligand binding properties of cultured primary keratinocytes. Cells were incubated 
with increasing concentrations of Alexa 647–labeled FNIII7-10 fragment in the absence (−) or presence (+) of 2 mM EDTA or 5 mM MnCl2, respectively, 
and analyzed by FACS. FNIII7-10 binding was similar between the mutant D/A (C) or YY/FF (D) keratinocytes and their respective controls. Mean ﬂ  uores-
cence intensities were corrected for background ﬂ  uorescence values. Error bars indicate SD. Shown is the mean of three independent experiments.β1 INTEGRIN ACTIVATION IN VIVO • CZUCHRA ET AL. 895
integrin is nonfunctional (Fig. 7 E, arrows). In 14-d-old mutant 
mice, LN5 was diffusely deposited at the epidermal–dermal 
junction in a manner similar to the β1- defi  cient  epidermis 
(Fig. 7 F).
To quantitatively assess the integrin levels on keratino-
cytes, we performed FACS analysis with freshly isolated keratino-
cytes from 6-d-old control and YY/AA mutant mice. The levels 
of β1, β4, and α6 integrin were reduced by  50% and the  levels 
of α2 integrin by  25% (Fig. 8 A). 9EG7 staining revealed 
  almost no signal on YY/AA keratinocytes, in contrast to con-
trols, suggesting that YY/AA integrins are present in an inactive 
conformation on mutant keratinocytes (Fig. 8 A).
The YY/AA mutant keratinocytes do not display the 
9EG7 epitope and show a 50% reduction of the β1 integrin 
expression on the cell surface. To confi  rm that the skin pheno-
types in mutant mice arose from the loss of talin–β1 integrin 
tail interaction and defective integrin activation and not from 
the reduced integrin expression, we established a mouse strain 
carrying a hypomorphic, wild-type β1 integrin allele (hpm). 
The hpm mouse strain was obtained by fusing a 141-bp cDNA 
fragment encoding the cytoplasmic domain of the β1 integrin 
gene in frame into exon 15, just behind the transmembrane 
span encoding sequence (Fig. S5, available at http://www.jcb.
org/cgi/content/full/jcb.200604060/DC1). Homozygous mice 
carrying the hpm allele died during development (unpublished 
data). To express the hpm mutation exclusively in keratinocytes, 
we intercrossed hpm mice with fl  oxed β1 integrin mice express-
ing the Cre recombinase under the K5 promoter (Brakebusch 
et al., 2000). Although freshly isolated hpm keratinocytes ex-
pressed only  25% of the normal β1 integrin level on their 
surface (Fig. 8 B), they developed a milder phenotype when 
compared with the YY/AA, which express 50% of the mutant 
β1 integrin (Fig. 7 A). At 2 wk of age, the hair coat of the hpm 
mice was slightly reduced and only a few of the hpm hair fol-
licles were misshapen and resembled the YY/AA or K5-β1 
phenotype (Fig. 7 B).   Similarly, the degree of epidermal hyper-
thickening, aberrant shape of basal keratinocytes, and extent 
of blistering was much less prominent in the hpm mice when 
compared with the YY/AA or K5-β1 mutant mice (Fig. 7 C and 
not depicted). LN5 deposition at the dermal–epidermal junction 
was broadened in hpm skin, although to a much lesser extent 
when compared with YY/AA and K5-β1 mutant skin (Fig. 7 F). 
Altogether, these data suggest that the phenotypic alterations 
observed in YY/AA mutant mice are likely caused by an im-
pairment of the talin–β1 integrin tail interaction, rather than a 
reduced β1 integrin expression.
YY/AA keratinocytes show impaired 
adhesion and an aberrant cytoskeleton 
in vitro
To analyze adhesion and cytoskeleton of YY/AA keratino-
cytes, freshly isolated mutant keratinocytes were seeded on 
Figure 7.  Keratinocyte-restricted expression 
of the YY/AA mutation in the 𝗃1A integrin cy-
toplasmic domain. (A) Control, YY/AA mutant, 
K5-β1 mutant, and hpm mutant mice at the 
age of 2 wk. YY/AA mutant and K5-β1 mutant 
mice have a reddish skin with a reduced num-
ber of hairs and blisters, whereas the hair coat 
of the hpm mice is only mildly affected. (B) HE-
stained parafﬁ  n sections of back skin derived 
from P14 mice show aberrant hair follicle mor-
phogenesis of the skin. The mutant hair follicles 
fail to grow as deeply into the subcutis as in 
the littermate control mice and are abnormally 
shaped. YY/AA and K5-β1 mutant mice have 
a hyperthickened epidermis and blisters be-
tween the epidermis and dermis (arrows). The 
hpm skin displays an intermediate phenotype. 
(C) High magniﬁ  cation of the HE-stained back 
skin section showing blister formation (arrows) 
and aberrant morphology of the basal kerati-
nocytes in YY/AA and K5-β1 mutant mice. 
(D) Control, YY/AA mutant, K5-β1 mutant, 
and hpm mutant epidermis examined for LacZ 
activity as a readout of Cre-mediated β1 integ-
rin gene deletion. LacZ-positive cells are visible 
in the epidermis and hair follicles of the YY/
AA, K5-β1, and hpm mutant mice. (E) Immuno-
staining of β1 (red) and α6 (green) integrins. 
Both integrin subunits are expressed on the sur-
face of basal and suprabasal keratinocytes 
(arrowheads) in the back skin section from P14 
YY/AA mutant mice. Blistering occurs indepen-
dently of the β1 integrin expression (arrows), 
suggesting a nonfunctional integrin. β1 integ-
rin expression is not detectable in K5-β1 and 
hpm mutant mice. Integrin α6 expression is 
discontinuous in YY/AA and K5-β1 mutant 
mice and normal in the hpm mice. (F) Similar to the conditional deletion of the β1 integrin gene in skin, introduction of the YY/AA mutation leads to diffuse 
LN5 deposition in the dermis of the mutant mice (asterisks). Basement membrane organization is only partially affected in the hpm mice. Bars, 50 μm.JCB • VOLUME 174 • NUMBER 6 • 2006  896
Col1/FN-coated plastic dishes. The majority of control cells ap-
peared well spread 24 h after plating and were confl  uent 72 h 
later. In sharp contrast, only a few mutant cells were attached 
24 h after seeding. They appeared round and failed to spread 
and proliferate (Fig. 9 A).
Immunostaining of the few adherent cells (cultured for 2 d 
on Col1 and FN) for β1 integrin, paxillin, and vinculin revealed 
a complete absence of FAs and stress fi  bers and the formation of 
F-actin clumps and/or fi  ne F-actin fi  laments extending radially 
from the perinuclear region to the plasma membrane. Almost 
the entire immune signal of β1 integrins and the FA compo-
nents was found within the cytoplasm (Fig. 9 B).   Altogether, 
these data suggest that the YY/AA mutation in the cytoplasmic 
domain of β1 integrins renders the integrins inactive.
Discussion
A key feature of integrins is their ability to switch between an 
inactive and an active conformation. It is believed that talin 
binding to the cytoplasmic domain of the β subunit disrupts the 
α/β tail interaction, leading to tail separation and changes in 
the conformation of the extracellular domain, consistent with 
integrin activation (Humphries et al., 2003; Calderwood, 2004). 
In the present study, we report the phenotypic analysis of 
mouse strains, which harbor point mutations in either the talin 
binding motif or the membrane-proximal salt bridge of the β1 
integrin subunit.
It has been shown that the substitution of the tyrosine 
residue with alanine in the proximal NPXY motif of β tails 
is suffi  cient to inhibit binding of talin and lock integrins in 
an inactive conformation (Tadokoro et al., 2003). To examine 
the consequences of this fi  nding during the development of a 
multicellular organism, we generated mice in which we sub-
stituted the tyrosine residues in the proximal and distal NPXY 
motifs of the β1 integrin subunit with alanine. We obtained 
compelling evidence that functional NPXY motifs are required 
for β1 integrin function both in vivo and in vitro. First, mice 
with a homozygous YY783/795AA (YY/AA) mutation die 
during   development. Second, expression of the YY/AA muta-
tion specifi  cally in keratinocytes mirrored the β1 integrin–null 
skin phenotype (Brakebusch et al., 2000) with epidermal hy-
perplasia, skin blistering, abnormal distribution of basement 
membrane proteins, and a dermal fi  brosis. Finally, primary ke-
ratinocytes from YY/AA mutant skin did not express detectable 
activated (9EG7-positive) β1 integrins and exhibited severely 
Figure 8.  Reduced integrin expression and activation on YY/AA mutant 
keratinocytes. Cell surface expression of integrins on freshly isolated keratino-
cytes from 6-d-old YY/AA (A) and 2.5-mo-old hpm mice (B) analyzed by 
FACS. (A) YY/AA keratinocytes are stained with antibodies against β1, 
α2, β4, and α6 integrins and the 9EG7 epitope of β1 integrins. Blue and 
black histograms denote control and YY/AA mutant keratinocytes, respec-
tively. Mutant YY/AA keratinocytes display a strongly reduced expression 
of β1, α2, β4, and α6 integrins and an almost complete absence of 9EG7 
signals. (B) hpm keratinocytes are stained with antibodies against β1 and 
α2 integrins. Blue and black histograms denote control and hpm mutant 
keratinocytes, respectively. Fusion of a wild-type 141-bp cDNA fragment 
encoding the cytoplasmic domain of the β1 integrin gene in frame into 
exon 15 of the β1 integrin gene reduces β1 integrin cell surface expres-
sion to 25% of wild-type expression levels. The background ﬂ  uorescence 
is shown as a dotted line. Shown are representative histograms from three 
independent experiments.
Figure 9.  Defective adhesion and spreading of YY/AA primary keratinocytes. 
(A) Freshly isolated keratinocytes plated at the same density on a mixture 
of Col1 and FN. Although control cells are well spread, mutant cells do 
not spread and adhere properly. Cells at the indicated time points after 
seeding are shown. Bar, 25 μm. (B) Keratinocytes were cultured for 2 d on 
a mixture of Col1 and FN and immunostained for β1 integrin, talin, vinculin 
(red), and F-actin (phalloidin; green). Nuclei were stained with DAPI (blue). 
YY/AA mutant cells fail to develop FAs and to organize the actin cytoskeleton. 
Shown are representative pictures from three independent experiments. 
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  compromised   integrin functions characterized by profound ad-
hesion defects, impaired spreading, FA assembly, and F-actin 
distribution. The YY/AA mutant keratinocytes expressed only 
 50% of the normal β1 integrin level on their cell surface. 
  Reduced surface expression of β1 integrin in the absence of 
talin binding is in agreement with a previous report showing 
that talin controls β1 integrin exit from an early compartment of 
the secretory pathway (Martel et al., 2000). To exclude the pos-
sibility that the reduced integrin levels rather than the abolished 
integrin activation is responsible for the YY/AA phenotype, we 
generated a hypomorphic β1 integrin mouse strain expressing 
only  25% of wild-type β1 integrins on keratinocytes. The 
hypomorphic mouse strain developed a much milder skin phe-
notype than the defects observed in the YY/AA mutant mice, 
which clearly suggests that loss of integrin activation rather 
than the reduced expression is responsible for the severe skin 
and hair abnormalities in YY/AA mutants.
Because integrins can quickly switch between an active 
and an inactive conformation, the binding of talin to the β inte-
grin tails must be tightly and effi  ciently regulated. Several stud-
ies reached the conclusion that this regulation may be achieved 
by reversibly phosphorylating the tyrosine residues of the β tail. 
In this model, tyrosine phosphorylation of the β tail NPXY mo-
tif by Src family kinases inhibits talin binding and displaces β1 
integrins from FA sites (Johansson et al., 1994; Sakai et al., 
2001; Datta et al., 2002). Inhibiting phosphorylation of the 
NPXY motif by substituting the tyrosine with a nonphosphory-
latable phenylalanine resulted in enhanced FN binding and as-
sembly (Sakai et al., 1998a), which was suggested to be due to 
enhanced talin binding to the NPXF motif.
We tested the role of tyrosine-783 and -795 phosphory-
lation in vivo by substituting either each tyrosine individually 
(Y783F and Y795F) or both together (YY783/795FF; YY/FF) 
with phenylalanine. Surprisingly, the mice with a single tyro-
sine mutation displayed no obvious defects. Moreover, mice 
with mutations in both tyrosine residues were also born with-
out phenotypic changes. When we searched the skin of YY/FF 
for subtle defects, we found normal keratinocyte layers in the 
  epidermis, normal keratinocyte proliferation, regular distribu-
tion of basement membrane proteins, absence of skin blisters, 
and normal hair follicle formation and cycling. Moreover, adhe-
sion, spreading, FA formation and distribution, F-actin organi-
zation, and migration were unaffected in freshly isolated YY/FF 
 mutant  keratinocytes.
The absence of abnormalities in YY/FF mice strongly in-
dicates that the mutant β1 integrin cytoplasmic tail is still able 
to recruit talin and activate the integrin. Furthermore, the in 
vivo fi  ndings also indicate that the YY/FF mutation still allows 
switching  β1 integrins between active and inactive confor-
mations. Several additional experiments confi  rm this notion. 
First, we found the surface levels of β1 integrins detected with 
an activation-associated epitope increased neither on kerati-
nocytes nor on hematopoietic cells. Second, we could induce 
integrin activation with Mn
2+ on keratinocytes and different 
hematopoietic cells to a similar extent as on the correspond-
ing control cells. Finally, migration-induced integrin activation 
triggered comparable FAK and Erk phosphorylation ( outside-in 
  signaling) in YY/FF mutant and control   keratinocytes. These 
observations allow some important conclusions: fi  rst, β1 in-
tegrin cytoplasmic tyrosine phosphorylation is dispensable to 
reverse talin-mediated integrin activation under physiological 
  conditions. It is possible that NPXF bound talin is released 
from the mutant β1 integrin cytoplasmic domain by other β1 
tail binding proteins, such as integrin cytoplasmic domain–
  associated protein (ICAP-1; Bouvard et al., 2003) or fi  lamin 
(Kiema et al., 2006). Second, β1 integrin cytoplasmic tyrosine 
phosphorylation plays no obvious role in integrin   outside-in 
signaling, although an increasing number of proteins are ca-
pable of binding the NPXY motifs, including myosin X and 
Kindlin-1 (Kloeker et al., 2004; Zhang et al., 2004).   However, 
it also possible that the integrin NPXY phosphorylation plays 
an important role during stress situations such as wound healing 
or infl  ammation, where cells move at high speed to restore tis-
sue   integrity. Such experiments are currently being performed 
in our laboratory.
The disruption of the membrane-proximal salt bridge be-
tween the α/β tails and their separation were suggested to be 
important steps toward integrin activation. Surprisingly, how-
ever, the destruction of this salt bridge by the substitution of 
the aspartic acid 759 with an alanine (D759A; D/A) in the β1 
membrane-proximal region produced no obvious phenotype. 
  Furthermore, freshly isolated keratinocytes or hematopoietic 
cells from the bone marrow of control and D/A mutant mice 
expressed low but similar levels of activated β1 integrins on 
their surface. Incubation of D/A mutant primary bone mar-
row cells with Mn
2+ induced integrin activation (as assessed 
with the 9EG7 antibody) to an extent similar to corresponding 
control cells. Moreover, adhesion, spreading, and migration 
of D/A mutant keratinocytes through transwell chambers was 
unaffected by the disruption of the α/β1 integrin salt bridge. 
Together, these data indicate that the genetic disruption of the 
membrane-proximal salt bridge between the α and the β1 in-
tegrin subunits neither locks β1 integrins in a more activated 
state nor increases their sensitivity to activation-inducing agents 
such as Mn
2+, permitting normal integrin function in vivo and 
in vitro.
Although our fi  ndings indicate that the salt bridge between 
the α and the β cytoplasmic domain plays no rate-limiting role 
for development and postnatal life of mice, previous biochemi-
cal and cell biological studies have demonstrated that the salt 
bridge plays an important function in integrin activation (Hughes 
et al., 1996), integrin clustering (Cluzel et al., 2005), and cell 
migration (Sakai et al., 2001). Interestingly, structural analysis 
of the αIIβ and β3 tails by nuclear magnetic resonance spec-
troscopy also produced confl  icting results. Although one group 
reported an interaction (Vinogradova et al., 2002, 2004), albeit 
a very weak one, two other reports failed to detect α/β tail inter-
actions (Li et al., 2001; Ulmer et al., 2001). It is possible that the 
weak, handshake-like interaction between the α/β tail exists but 
plays a less important role as long as other α/β interactions are 
present, for example, in the membrane-spanning helical regions 
(Gottschalk et al., 2002; Schneider and Engelman, 2004). This 
can be rigorously tested by introducing specifi  c mutations into 
the transmembrane domain of β integrin subunits.JCB • VOLUME 174 • NUMBER 6 • 2006  898
Materials and methods
Generation of mutant mice
Mouse genomic clones used to generate the targeting constructs were 
described previously (Fässler and Meyer, 1995). The loxP-ﬂ  anked neo-
mycin cassette was inserted into either the NcoI site upstream of exon 
15 (Fig. 2 A) or into the PstI site upstream of exon 16 (Fig. 2 B). Both 
constructs were used to produce mice (E15
neo+ and E16
neo+). Point mu-
tations were introduced in exon 15 and 16 using the AlteredSites II in 
vitro mutagenesis system (Promega). The D/A mutation was subsequently 
transferred into the E15
neo+ construct, and the F and A mutants were 
introduced into the E16
neo+ construct. The targeting constructs were elec-
troporated into R1 ES cells. ES cell clones that underwent homologous 
recombination were isolated, identiﬁ  ed by Southern blot using BamHI-
digested genomic DNA and a 1-kb 3′ external probe, and injected into 
blastocysts to generate germline chimeras. Upon germline transmission, 
mutant mice were intercrossed with deleter-Cre transgenic mice (Betz 
et al., 1996) to obtain heterozygous E15
lox, E16
lox, D/A, Y783F, Y795F, 
YY/FF, and YY/AA mutant mice, which were subsequently interbred to 
obtain homozygous mutant mice. For all experiments performed with 
these mouse lines, either heterozygous or wild-type littermates served 
as control animals. Because YY/AA mutants were embryonic lethal, 
they were intercrossed with mice carrying a ﬂ   oxed β1 integrin gene 
(  Brakebusch et al., 2000) and mice carrying K5 promoter-driven Cre 
recombinase transgene (Ramirez et al., 2004). Littermates carrying the 
ﬂ   oxed and the YY/AA mutated β1 integrin allele without the Cre re-
combinase transgene served as controls for experiments performed with 
the YY/AA mutant. Genotyping was performed by Southern blot or PCR 
using DNA isolated from tail biopsies. All animal studies were approved 
by the Regierung von Oberbayern.
RT-PCR
For RT-PCR, 50 ng of total RNA were reverse-transcribed using the   iScript 
synthesis kit (Bio-Rad Laboratories), according to the manufacturer’s   protocol. 
The single-strand cDNA was used as a template for a PCR reaction, using 
a forward primer hybridizing to exon 14 (5′-A  G  G  A  C  A  T  T  G  A  T  G  A  C  T  G-
CTG  G  -3′) and a reverse primer hybridizing to exon 16 (5′-C  C  A  A  A  A  C  T  A-
C  C  C  T  A  C  T  G  T  G  A  C  -3′) of the β1 integrin gene.
Histology and immunoﬂ  uorescence
Hematoxylin-eosin (HE) and immunoﬂ  uorescence staining were performed 
as described previously (Brakebusch et al., 2000). Because freshly isolated 
keratinocytes adhere and spread slowly on ECM substrata, all immuno-
stainings on primary cells were performed after 48 h. BrdU staining was 
performed according to the manufacturer’s instructions (Roche   Diagnostics). 
β-Galactosidase activity was determined as previously described (Fässler 
and Meyer, 1995).
The following antibodies were used: β1 integrin (Chemicon), 
LN5 (lamininγ2 chain; provided by T. Sasaki, Max Planck Institute of 
Biochemistry, Martinsried, Germany), BrdU-POD (Roche Diagnostics), 
paxillin (BD Biosciences), α6 integrin–FITC (BD Biosciences), vinculin 
(Sigma-Aldrich), talin (Sigma-Aldrich), phalloidin–Alexa 488 (Invitro-
gen), FAK (Upstate Biotechnology), phospho(p)-Y397FAK (Biosource 
International), p42/p44 MAPK (Cell Signaling), and α-tubulin (clone 
YL1/2; provided by J. Wehland, German Research Center for Biotech-
nology,   Braunschweig, Germany). Fluorescence-conjugated secondary 
antibodies (goat anti–rat-Cy3, goat anti–mouse Cy3, goat anti–  rabbit 
FITC, and donkey anti–rabbit Cy3) were purchased from Jackson Immuno-
Research Laboratories, and goat anti–rabbit Alexa 488 was obtained from 
Sigma-  Aldrich. Antibodies were diluted according to the recommendation 
of the manufacturer.
Images were collected by confocal microscopy (DMIRE2; Leica) us-
ing Leica Confocal Software version 2.5 Build 1227 with 40× or 63× oil 
objectives, by ﬂ  uorescence microscopy (DMRA2; Leica) using SimplePCI 
software (version 5.1.0.0110; GTI Microsystems) with 63× oil objectives, 
or by bright ﬁ  eld microscopy (Axiovert; Carl Zeiss MicroImaging, Inc.), us-
ing IM50 software (Leica) with 10× or 40× objectives. All images were 
collected at RT. Immunoﬂ  uorescence staining intensities from talin and FAK 
confocal images (detected by Cy3- and Alexa 488–coupled secondary 
antibodies, respectively) were quantiﬁ  ed using the Leica Confocal  Software. 
In brief, confocal stacks with highest talin ﬂ   uorescence intensities were 
  selected, and single FAs were selected for quantiﬁ  cation. The mean ﬂ  uo-
rescence amplitude of talin and FAK of each FA was used to perform the 
ratiometric analysis shown in Fig. 4 E. Images were processed with 
  Photoshop (Adobe).
Isolation of primary keratinocytes, adhesion, spreading, 
and migration assays
Primary keratinocytes were isolated from P6 or adult mice according to 
Romero et al. (1999) and grown to conﬂ  uence on a mixture of Col1 (Cohe-
sion) and 10 μg/ml FN (Invitrogen) coated plastic in keratinocyte growth 
medium containing 8% chelated FCS (Invitrogen) and 45 μM Ca
2+.
To test keratinocyte migration, transwell chambers (Falcon) with 
8-μm-diameter pores were coated on the lower surfaces with a mixture of 
Col1 and 10 μg/ml FN. In duplicate assays, 4 × 10
4 primary keratino-
cytes were suspended in 45 μM calcium-containing Eagle’s minimum 
  essential medium (Sigma-Aldrich) supplemented with 1× L-glutamine (Invit-
rogen) and seeded onto the transwell chambers. The chambers were 
placed in keratinocyte growth medium with or without 50 ng/ml EGF 
(Sigma-Aldrich) and incubated for 14 h at 37°C. Afterward, cells in the up-
per surface of the membrane were removed and the cells on the lower sur-
face ﬁ  xed and stained with 20% methanol/0.1% crystal violet. The relative 
number of migrated cells (compared with the number of all attached cells) 
was determined from ﬁ  ve randomly chosen microscopic ﬁ  elds of  1.2 mm
2 
per duplicate experiment.
Cell adhesion of primary keratinocytes to LN5 (provided by 
M.   Aumailley, University of Cologne, Cologne, Germany), FN, and Col1 
was assayed as described previously (Hamelers et al., 2005). All experi-
ments have been performed in duplicate.
To assess the spreading kinetics of primary keratinocytes, cells were 
plated on mixture of Col1 and 10 μg/ml FN–coated plastic and monitored 
at 37°C in 5% CO2 by phase-contrast live cell imaging microscopy using a 
microscope (Axiovert 200M ; Carl Zeiss MicroImaging, Inc.) coupled to a 
camera (Visitron Systems). Images were collected with 10× objective. The 
cell area of 50 randomly selected cells per time point and genotype was 
quantiﬁ  ed using MetaMorph 6.0 software (Molecular Devices). Wound heal-
ing assays and the measurement of the activity of signaling molecules upon 
wounding was performed as described previously (  Czuchra et al., 2005).
Expression of FN fragment FnIII7-10
An expression plasmid (obtained from H.P. Erickson, Duke University Med-
ical Center, Durham, NC) encoding a His-tagged version of FN type III re-
peats 7–10 (FnIII7-10) containing the central cell binding domain (Ohashi 
and Erickson, 2005) was used to express FnIII7-10 in Escherichia coli. 
  Recombinant FnIII7-10 polypeptides were puriﬁ   ed by TALON Metal Af-
ﬁ   nity chromatography according to the manufacturer’s instructions (BD 
  Biosciences). The ﬁ  nal preparation was dialyzed in PBS. To label FnIII7-10 
polypeptides with a ﬂ   uorescent probe, the puriﬁ  ed fragment (2 mg/ml) 
was ﬁ  rst adjusted to pH 8.4 and subsequently incubated with 1 mg of 
Alexa Fluor 647 carboxylic acid and succidimidyl ester (Invitrogen) for 
1 h at RT. The uncoupled probe was removed by dialysis in two changes 
of PBS at 4°C.
FNIII7-10 binding assay
To assess ligand binding properties of primary keratinocytes, conﬂ  uent 
cells were harvested and incubated (3 × 10
5 cells per sample) with Alexa 
647–coupled FNIII7-10 fragment in Tris-buffered saline in the presence or 
absence of 2 mM EDTA or 5 mM MnCl2 and, ﬁ  nally, subjected to ﬂ  ow cy-
tometry analysis.
Flow cytometry
Freshly isolated keratinocytes (5 × 10
5 cells per sample) were stained with 
antibodies against α6 integrin, α2 integrin, β1 integrin (Ha2/5 epitope; 
recognizes all β1 integrin subunits), β1 integrin (9EG7 epitope; recog-
nizes an activation-associated epitope and hence only activated β1 integ-
rins), or β4 integrin and subjected to FACS analysis (Potocnik et al., 2000). 
All antibodies were either FITC labeled or unlabeled and used in a 1:200 
dilution, except 9EG7, which was used in a 1:100 dilution. Unlabeled an-
tibodies were visualized with FITC α-rat IgG2a (1:200). All antibodies were 
obtained from BD Biosciences. Dead cells were excluded from FACS analy-
sis by the addition of 2.5 μg/ml propidium iodide before FACS analysis 
(FACSCalibur CellQuest Pro Software; Becton Dickinson).
Freshly prepared single-cell bone marrow suspensions (10
6 cells per 
sample; Rutherford and Schook, 1992) were stained with the β1   integrin–
speciﬁ  c antibodies Ha2/5 or 9EG7 in Tris-buffered saline, containing 3% 
BSA with or without 5 mM MnCl2 (Bazzoni and Hemler, 1998). In ad-
dition, cells were counterstained with antibodies against CD45R/B220 
(B cell marker), Ly6G/Gr-1 (granulocyte marker), CD11b/Mac-1 (macro-
phage marker), or Ly-76/Ter-119 (erythroblast/erythrocyte marker), which 
were either PE-labeled or biotinylated. Biotinylated antibodies were de-
tected with Streptavidin-Cy5 (Jackson ImmunoResearch Laboratories).β1 INTEGRIN ACTIVATION IN VIVO • CZUCHRA ET AL. 899
Online supplemental material
Fig. S1 shows the development of the lox/lox mice and mice carrying 
a single Y/F mutation. Fig. S2 shows the weight and size of aging D/A 
and YY/FF mutant mice. Fig. S3 shows the FA and stress ﬁ  ber formation 
in YY/FF mutant keratinocytes. Fig. S4 shows the β1 integrin expression 
and activation on E15
lox/lox, D/A, E16
lox/lox, and YY/FF bone marrow cells. 
Fig. S5 shows the targeting strategy used to obtain the hpm mice. Online 
supplemental material is available at http://www.jcb.org/cgi/content/
full/jcb.200604060/DC1.
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